Dabur Pharma gets USFDA approval for selling ‘Mitoxantrone HCL’

Submitted by Nalin Grover on Tue, 05/20/2008 - 20:09

Dabur Pharma Ltd's oncology unit has informed that the company has received the approval from US Food and Drug Administrator (USFDA) for selling 'Mitoxantrone Hydrochloride in various strengths’.

Dabur Pharma Ltd operates in Europe and other overseas markets through its fully-owned subsidiary, Dabur Oncology Plc.

The drug is indicated for reducing neurologic disability and /or the frequency of clinical relapses in patients with secondary chronic progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly abnormal between relapses).


Tagged with

Miscellaneous

Government to issue clarifications on FDI in multi-brand retail

Government to issue clarifications on FDI in multi-brand retail

The government in India is planning to release clarifications to the regulations relating to the foreign direct investment in multi-brand retail.

Department of Industrial Policy and Planning officials have said that they have received a number of quarries from various global retail players for clarifications on various matters including sourcing arrangements. Foreign retailers will be permitted to include only processed food items form small enterprises under the mandatory sourcing regulations.

Tata Sons cancels stake sale in TTML

Tata Sons cancels stake sale in TTML

Tata Sons Ltd on Friday confirmed that its decision to cancel its offer for sale (OFS) of shares in its subsidiary Tata Teleservices (Maharashtra) Ltd.

The OFS was announced on Wednesday, when Tata Sons said that it would sell a total of 51,623,679 shares, or 2.72 per cent of the equity capital of the Tata Teleservices (Maharashtra) Ltd, on May 17.

But, the company yesterday confirmed that it had cancelled the sale. In a filing to the Bombay Stock Exchange (BSE), the company said, "Tata Sons Limited has now informed BSE that they have decided to cancel the sale in full."

© Copyright 2013